Clinical Trials Browser

Phase 1 × Not yet recruiting × Lutetium × Clear all

NCT07244393 2025-11-24

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Phase 1 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT06553846 2024-08-14

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors